← SynDRA
SYN0050020
SynDRA canonical compound SYN0050020 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | NUAK1 | NUAK2 |
|---|
| Mechanism of action | AMPK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- NUAK1 INHIBITOR
- NUAK2 INHIBITOR
- AMPK inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- GPR119
- FPR1
- GPR183
- ADGRF1
- TDG
- SMUG1
- S1PR1
- OGG1
- NTHL1
- NEIL2
- NEIL1
- GPR35
- GLP1R
- ADRA2A
- FPR3
- FPR2
- FFAR4
- CX3CR1
- C5AR1
- APLNR
- AGTR1
- ADRB2
- UNG
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- WZ-4003
- WZ4003
- RefChem:902249
- DTXCID701542096
- WZ 4003
- C25H29ClN6O3
- MFCD28015100
- GTPL8047
- orb1300897
- SCHEMBL29504107
- SCHEMBL31060495
- GLXC-05510
- HMS3653E12
- HMS3674E13
- EX-A2485
- PYB26558
- BDBM50587675
- s7317
- AKOS025142058
- CCG-264737
- CS-3258
- EBC-218035
- NCGC00386309-05
- NCGC00386309-06
- NCGC00386309-07
- AC-30128
- AS-55863
- HY-15802
- WZ-4003?
- WZ4003, >=98% (HPLC)
- SW220181-1
- T6291
- F20676
- EN300-20128562
- BRD-K45909031-001-01-5
- WYT
Look up SYN0050020 in the interactive SynDRA portal →